Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Res

Retrieve available abstracts of 193 articles:
HTML format
Text format



Single Articles


    August 2019
  1. MUNESWARAO J, Hassali MA, Ibrahim B, Saini B, et al
    It is time to change the way we manage mild asthma: an update in GINA 2019.
    Respir Res. 2019;20:183.
    PubMed     Text format     Abstract available


  2. EDRIS A, De Feyter S, Maes T, Joos G, et al
    Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis.
    Respir Res. 2019;20:179.
    PubMed     Text format     Abstract available


  3. LEE KM, Lee G, Kim A, Mok J, et al
    Clinical outcomes of radial probe endobronchial ultrasound using a guide sheath for diagnosis of peripheral lung lesions in patients with pulmonary emphysema.
    Respir Res. 2019;20:177.
    PubMed     Text format     Abstract available


  4. LEATHER DA, Yates L, Svedsater H, Jacques L, et al
    Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?
    Respir Res. 2019;20:173.
    PubMed     Text format     Abstract available


    July 2019
  5. ALBERS FC, Papi A, Taille C, Bratton DJ, et al
    Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.
    Respir Res. 2019;20:169.
    PubMed     Text format     Abstract available


  6. YANG J, Ramirez Moral I, van 't Veer C, de Vos AF, et al
    Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.
    Respir Res. 2019;20:165.
    PubMed     Text format     Abstract available


  7. KIM W, Cho MH, Sakornsakolpat P, Lynch DA, et al
    DSP variants may be associated with longitudinal change in quantitative emphysema.
    Respir Res. 2019;20:160.
    PubMed     Text format     Abstract available


  8. HALPIN DMG, Meltzer EO, Pisternick-Ruf W, Moroni-Zentgraf P, et al
    Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1.
    Respir Res. 2019;20:159.
    PubMed     Text format     Abstract available


  9. PIGNATTI P, Visca D, Cherubino F, Zampogna E, et al
    Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.
    Respir Res. 2019;20:145.
    PubMed     Text format     Abstract available


    June 2019
  10. O'BRIEN ME, Chandra D, Wilson RC, Karoleski CM, et al
    Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers.
    Respir Res. 2019;20:128.
    PubMed     Text format     Abstract available


  11. LIU F, Qu F, Zhang H, Chao L, et al
    The effect and burden modification of heating on adult asthma hospitalizations in Shijiazhuang: a time-series analysis.
    Respir Res. 2019;20:122.
    PubMed     Text format     Abstract available


    May 2019
  12. NELSEN LM, Lee LA, Wu W, Lin X, et al
    Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap.
    Respir Res. 2019;20:107.
    PubMed     Text format     Abstract available


  13. XIONG XF, Zhu M, Wu HX, Fan LL, et al
    Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials.
    Respir Res. 2019;20:108.
    PubMed     Text format     Abstract available


  14. UM-BERGSTROM P, Hallberg J, Pourbazargan M, Berggren-Brostrom E, et al
    Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia differ from patients with asthma.
    Respir Res. 2019;20:102.
    PubMed     Text format     Abstract available


  15. OCCHIPINTI M, Paoletti M, Bartholmai BJ, Rajagopalan S, et al
    Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD.
    Respir Res. 2019;20:101.
    PubMed     Text format     Abstract available


  16. LIU L, Zhang X, Liu Y, Zhang L, et al
    Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.
    Respir Res. 2019;20:95.
    PubMed     Text format     Abstract available


  17. TRABELSI S, Casas L, Nemery B, Nawrot TS, et al
    Geographies of asthma medication purchase for pre-schoolers in Belgium.
    Respir Res. 2019;20:90.
    PubMed     Text format    


  18. PRAZMA CM, Bel EH, Price RG, Bradford ES, et al
    Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis.
    Respir Res. 2019;20:83.
    PubMed     Text format     Abstract available


    April 2019
  19. KANG HR, Hong SH, Ha SY, Kim TB, et al
    Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea.
    Respir Res. 2019;20:80.
    PubMed     Text format     Abstract available


  20. TURA-CEIDE O, Pizarro S, Garcia-Lucio J, Ramirez J, et al
    Progenitor cell mobilisation and recruitment in pulmonary arteries in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:74.
    PubMed     Text format     Abstract available


  21. QI Q, Ailiyaer Y, Liu R, Zhang Y, et al
    Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial.
    Respir Res. 2019;20:73.
    PubMed     Text format     Abstract available


  22. FAIZ A, van den Berge M, Vermeulen CJ, Ten Hacken NHT, et al
    AGER expression and alternative splicing in bronchial biopsies of smokers and never smokers.
    Respir Res. 2019;20:70.
    PubMed     Text format     Abstract available


  23. HO TW, Huang CT, Tsai YJ, Lien AS, et al
    Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:69.
    PubMed     Text format     Abstract available


  24. ZHU Z, Wang X, Li X, Lin Y, et al
    Genetic overlap of chronic obstructive pulmonary disease and cardiovascular disease-related traits: a large-scale genome-wide cross-trait analysis.
    Respir Res. 2019;20:64.
    PubMed     Text format     Abstract available


  25. MORROW JD, Chase RP, Parker MM, Glass K, et al
    RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD.
    Respir Res. 2019;20:65.
    PubMed     Text format     Abstract available


  26. RONNOW SR, Sand JMB, Langholm LL, Manon-Jensen T, et al
    Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
    Respir Res. 2019;20:63.
    PubMed     Text format     Abstract available


    March 2019
  27. LEE SH, Lee JH, Yoon HI, Park HY, et al
    Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.
    Respir Res. 2019;20:62.
    PubMed     Text format     Abstract available


  28. ALTER P, Watz H, Kahnert K, Rabe KF, et al
    Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD.
    Respir Res. 2019;20:61.
    PubMed     Text format     Abstract available


  29. NAYA I, Tombs L, Lipson DA, Boucot I, et al
    Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis.
    Respir Res. 2019;20:60.
    PubMed     Text format     Abstract available


  30. HIGHAM A, Quinn AM, Cancado JED, Singh D, et al
    The pathology of small airways disease in COPD: historical aspects and future directions.
    Respir Res. 2019;20:49.
    PubMed     Text format     Abstract available


    February 2019
  31. KHAKBAN A, FitzGerald JM, Tavakoli H, Lynd L, et al
    Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study.
    Respir Res. 2019;20:44.
    PubMed     Text format     Abstract available


  32. STOEL BC, Stolk J, Bakker ME, Parr DG, et al
    Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values.
    Respir Res. 2019;20:45.
    PubMed     Text format     Abstract available


  33. SUGAWARA H, Saito A, Yokoyama S, Tsunematsu K, et al
    Comparison of therapeutic effects of inhaled corticosteroids on three subtypes of cough variant asthma as classified by the impulse oscillometry system.
    Respir Res. 2019;20:41.
    PubMed     Text format     Abstract available


  34. ZILAEE M, Hosseini SA, Jafarirad S, Abolnezhadian F, et al
    An evaluation of the effects of saffron supplementation on the asthma clinical symptoms and asthma severity in patients with mild and moderate persistent allergic asthma: a double-blind, randomized placebo-controlled trial.
    Respir Res. 2019;20:39.
    PubMed     Text format     Abstract available


  35. LI HF, Yan LP, Wang K, Li XT, et al
    Association between ADAM33 polymorphisms and asthma risk: a systematic review and meta-analysis.
    Respir Res. 2019;20:38.
    PubMed     Text format     Abstract available


  36. BROWN MN, Fuhr R, Beier J, Su HL, et al
    Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial.
    Respir Res. 2019;20:37.
    PubMed     Text format     Abstract available


  37. FLEXEDER C, Zock JP, Jarvis D, Verlato G, et al
    Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey.
    Respir Res. 2019;20:33.
    PubMed     Text format     Abstract available


  38. CORSICO AG, D'Armini AM, Conio V, Sciortino A, et al
    Persistent exercise limitation after successful pulmonary endoarterectomy: frequency and determinants.
    Respir Res. 2019;20:34.
    PubMed     Text format     Abstract available


  39. VON SIEMENS SM, Jorres RA, Behr J, Alter P, et al
    Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study.
    Respir Res. 2019;20:30.
    PubMed     Text format     Abstract available


  40. SUN SW, Chen L, Zhou M, Wu JH, et al
    BAMBI regulates macrophages inducing the differentiation of Treg through the TGF-beta pathway in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:26.
    PubMed     Text format     Abstract available


    January 2019
  41. ZHOU T, Huang X, Ma J, Zhou Y, et al
    Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China.
    Respir Res. 2019;20:19.
    PubMed     Text format     Abstract available


  42. LU Y, Chang R, Yao J, Xu X, et al
    Effectiveness of long-term using statins in COPD - a network meta-analysis.
    Respir Res. 2019;20:17.
    PubMed     Text format     Abstract available


  43. SRIDHAR S, Liu H, Pham TH, Damera G, et al
    Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases.
    Respir Res. 2019;20:14.
    PubMed     Text format     Abstract available


  44. KUBO F, Ariestanti DM, Oki S, Fukuzawa T, et al
    Loss of the adhesion G-protein coupled receptor ADGRF5 in mice induces airway inflammation and the expression of CCL2 in lung endothelial cells.
    Respir Res. 2019;20:11.
    PubMed     Text format     Abstract available


  45. WEDZICHA JA, Singh D, Tsiligianni I, Jenkins C, et al
    Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.
    Respir Res. 2019;20:4.
    PubMed     Text format     Abstract available


  46. FANER R, Morrow JD, Casas-Recasens S, Cloonan SM, et al
    Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis.
    Respir Res. 2019;20:5.
    PubMed     Text format     Abstract available


  47. ERRIAH M, Pabreja K, Fricker M, Baines KJ, et al
    Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma.
    Respir Res. 2019;20:1.
    PubMed     Text format     Abstract available


  48. MORICHIKA D, Miyahara N, Fujii U, Taniguchi A, et al
    A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation.
    Respir Res. 2019;20:2.
    PubMed     Text format     Abstract available


    December 2018
  49. CRISAFULLI E, Ielpo A, Barbeta E, Ceccato A, et al
    Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.
    Respir Res. 2018;19:261.
    PubMed     Text format     Abstract available


  50. BHATT SP, Nath HP, Kim YI, Ramachandran R, et al
    Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.
    Respir Res. 2018;19:257.
    PubMed     Text format     Abstract available


  51. GAFAR F, Boudewijn IM, Cox CA, Vonk JM, et al
    Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Res. 2018;19:256.
    PubMed     Text format     Abstract available


  52. WATZ H, Tetzlaff K, Magnussen H, Mueller A, et al
    Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
    Respir Res. 2018;19:251.
    PubMed     Text format     Abstract available


  53. LENOIR A, Fitting JW, Marques-Vidal PM, Vollenweider P, et al
    GLI 2012 equations define few spirometric anomalies in the general population: the PneumoLaus study.
    Respir Res. 2018;19:250.
    PubMed     Text format     Abstract available


  54. NEVILLE MDC, Choi J, Lieberman J, Duan QL, et al
    Identification of deleterious and regulatory genomic variations in known asthma loci.
    Respir Res. 2018;19:248.
    PubMed     Text format     Abstract available


  55. FLYNN RWV, MacDonald TM, Chalmers JD, Schembri S, et al
    The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.
    Respir Res. 2018;19:249.
    PubMed     Text format     Abstract available


  56. ERIKSSON STROM J, Pourazar J, Linder R, Blomberg A, et al
    Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking.
    Respir Res. 2018;19:244.
    PubMed     Text format     Abstract available


  57. PEREZ-BAUTISTA O, Montano M, Perez-Padilla R, Zuniga-Ramos J, et al
    Women with COPD by biomass show different serum profile of adipokines, incretins, and peptide hormones than smokers.
    Respir Res. 2018;19:239.
    PubMed     Text format     Abstract available


  58. GREGORIANO C, Dieterle T, Breitenstein AL, Durr S, et al
    Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
    Respir Res. 2018;19:237.
    PubMed     Text format     Abstract available


    November 2018
  59. ROSCIOLI E, Hamon R, Lester SE, Jersmann HPA, et al
    Airway epithelial cells exposed to wildfire smoke extract exhibit dysregulated autophagy and barrier dysfunction consistent with COPD.
    Respir Res. 2018;19:234.
    PubMed     Text format     Abstract available


  60. LI F, Xu M, Wang M, Wang L, et al
    Roles of mitochondrial ROS and NLRP3 inflammasome in multiple ozone-induced lung inflammation and emphysema.
    Respir Res. 2018;19:230.
    PubMed     Text format     Abstract available


  61. LEWIS TC, Metitiri EE, Mentz GB, Ren X, et al
    Influence of viral infection on the relationships between airway cytokines and lung function in asthmatic children.
    Respir Res. 2018;19:228.
    PubMed     Text format     Abstract available


  62. MILARA J, Diaz-Platas L, Contreras S, Ribera P, et al
    MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease.
    Respir Res. 2018;19:226.
    PubMed     Text format     Abstract available


  63. DRIESSEN MT, Whalen J, Seewoodharry Buguth B, Vallejo-Aparicio LA, et al
    Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
    Respir Res. 2018;19:224.
    PubMed     Text format     Abstract available


  64. XU W, Li R, Guan L, Wang K, et al
    Combination of inspiratory and expiratory muscle training in same respiratory cycle versus different cycles in COPD patients: a randomized trial.
    Respir Res. 2018;19:225.
    PubMed     Text format     Abstract available


  65. PIROZZI CS, Gu T, Quibrera PM, Carretta EE, et al
    Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
    Respir Res. 2018;19:223.
    PubMed     Text format     Abstract available


  66. NAYA IP, Tombs L, Muellerova H, Compton C, et al
    Long-term outcomes following first short-term clinically important deterioration in COPD.
    Respir Res. 2018;19:222.
    PubMed     Text format     Abstract available


  67. YANG J, Luo J, Yang L, Yang D, et al
    Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: a meta-analysis and systematic review.
    Respir Res. 2018;19:217.
    PubMed     Text format     Abstract available


  68. RUTTING S, Papanicolaou M, Xenaki D, Wood LG, et al
    Dietary omega-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD.
    Respir Res. 2018;19:211.
    PubMed     Text format     Abstract available


    October 2018
  69. HAYDEN LP, Cho MH, Raby BA, Beaty TH, et al
    Childhood asthma is associated with COPD and known asthma variants in COPDGene: a genome-wide association study.
    Respir Res. 2018;19:209.
    PubMed     Text format     Abstract available


  70. LO D, Kennedy JL, Kurten RC, Panettieri RA Jr, et al
    Modulation of airway hyperresponsiveness by rhinovirus exposure.
    Respir Res. 2018;19:208.
    PubMed     Text format     Abstract available


  71. TASHKIN DP, Miravitlles M, Celli BR, Metzdorf N, et al
    Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT(R) trial.
    Respir Res. 2018;19:196.
    PubMed     Text format     Abstract available


    September 2018
  72. DOMINGO C, Palomares O, Sandham DA, Erpenbeck VJ, et al
    The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation.
    Respir Res. 2018;19:189.
    PubMed     Text format     Abstract available


  73. PARK HJ, Byun MK, Rhee CK, Kim K, et al
    Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study.
    Respir Res. 2018;19:185.
    PubMed     Text format     Abstract available


  74. KIRENGA BJ, Mugenyi L, de Jong C, Lucian Davis J, et al
    The impact of HIV on the prevalence of asthma in Uganda: a general population survey.
    Respir Res. 2018;19:184.
    PubMed     Text format     Abstract available


  75. STRODA A, Brandenburg V, Daher A, Cornelissen C, et al
    Serum phosphate and phosphate-regulatory hormones in COPD patients.
    Respir Res. 2018;19:183.
    PubMed     Text format     Abstract available


  76. CRISFORD H, Sapey E, Stockley RA
    Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases.
    Respir Res. 2018;19:180.
    PubMed     Text format     Abstract available


  77. ZIYAB AH, Mukherjee N, Kurukulaaratchy RJ, Zhang H, et al
    Leptin receptor gene polymorphisms and sex modify the association between acetaminophen use and asthma among young adults: results from two observational studies.
    Respir Res. 2018;19:179.
    PubMed     Text format     Abstract available


  78. HAGHIGHI B, Choi S, Choi J, Hoffman EA, et al
    Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
    Respir Res. 2018;19:178.
    PubMed     Text format     Abstract available


  79. TONGA KO, King GG, Farah CS, Thamrin C, et al
    Steroid insensitive fixed airflow obstruction is not related to airway inflammation in older non-smokers with asthma.
    Respir Res. 2018;19:176.
    PubMed     Text format     Abstract available


  80. BARRECHEGUREN M, Gonzalez C, Miravitlles M
    What have we learned from observational studies and clinical trials of mild to moderate COPD?
    Respir Res. 2018;19:177.
    PubMed     Text format     Abstract available


  81. WINKLER A, Kahnert K, Behr J, Neurohr C, et al
    Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation.
    Respir Res. 2018;19:171.
    PubMed     Text format     Abstract available


  82. JANSON C, Johansson G, Stallberg B, Lisspers K, et al
    Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study.
    Respir Res. 2018;19:172.
    PubMed     Text format     Abstract available


  83. WATANABE M, Nakamoto K, Inui T, Sada M, et al
    Serum sST2 levels predict severe exacerbation of asthma.
    Respir Res. 2018;19:169.
    PubMed     Text format     Abstract available


  84. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR).
    Respir Res. 2018;19:168.
    PubMed     Text format     Abstract available


    August 2018
  85. MUELLER S, Gottschalk F, Groth A, Meeraus W, et al
    Primary data, claims data, and linked data in observational research: the case of COPD in Germany.
    Respir Res. 2018;19:161.
    PubMed     Text format     Abstract available


  86. MATUCCI A, Vultaggio A, Danesi R
    The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review.
    Respir Res. 2018;19:154.
    PubMed     Text format     Abstract available


  87. BURBANK AJ, Todoric K, Steele P, Rosen J, et al
    Age and African-American race impact the validity and reliability of the asthma control test in persistent asthmatics.
    Respir Res. 2018;19:152.
    PubMed     Text format     Abstract available


  88. GREULICH T, Rodriguez-Frias F, Belmonte I, Klemmer A, et al
    Real world evaluation of a novel lateral flow assay (AlphaKit(R) QuickScreen) for the detection of alpha-1-antitrypsin deficiency.
    Respir Res. 2018;19:151.
    PubMed     Text format     Abstract available


  89. ATANASOVA KR, Reznikov LR
    Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.
    Respir Res. 2018;19:149.
    PubMed     Text format     Abstract available


  90. JOHNSON KM, Tan WC, Bourbeau J, Sin DD, et al
    The diagnostic performance of patient symptoms in screening for COPD.
    Respir Res. 2018;19:147.
    PubMed     Text format     Abstract available


  91. REEVES SR, Kang I, Chan CK, Barrow KA, et al
    Asthmatic bronchial epithelial cells promote the establishment of a Hyaluronan-enriched, leukocyte-adhesive extracellular matrix by lung fibroblasts.
    Respir Res. 2018;19:146.
    PubMed     Text format     Abstract available


  92. MOHEIMANI F, Koops J, Williams T, Reid AT, et al
    Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics.
    Respir Res. 2018;19:145.
    PubMed     Text format     Abstract available


    July 2018
  93. WILLIAMS NP, Ostridge K, Devaster JM, Kim V, et al
    Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD.
    Respir Res. 2018;19:143.
    PubMed     Text format     Abstract available


  94. XU S, Tsai A, Sze MA, Vucic EA, et al
    Decreased microbiome diversity in the HIV small airway epithelium.
    Respir Res. 2018;19:140.
    PubMed     Text format     Abstract available


  95. STOCKLEY RA, Edgar RG, Starkey S, Turner AM, et al
    Health status decline in alpha-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?
    Respir Res. 2018;19:137.
    PubMed     Text format     Abstract available


  96. BARDSLEY G, Daley-Yates P, Baines A, Kempsford R, et al
    Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.
    Respir Res. 2018;19:133.
    PubMed     Text format     Abstract available


  97. SHIN SH, Park HY, Kang D, Cho J, et al
    Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease.
    Respir Res. 2018;19:134.
    PubMed     Text format     Abstract available


    June 2018
  98. PHILPOTT CM, Erskine S, Hopkins C, Kumar N, et al
    Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
    Respir Res. 2018;19:129.
    PubMed     Text format     Abstract available


  99. BURGEL PR, Laurendeau C, Raherison C, Fuhrman C, et al
    An attempt at modeling COPD epidemiological trends in France.
    Respir Res. 2018;19:130.
    PubMed     Text format     Abstract available


  100. KHO AT, McGeachie MJ, Moore KG, Sylvia JM, et al
    Circulating microRNAs and prediction of asthma exacerbation in childhood asthma.
    Respir Res. 2018;19:128.
    PubMed     Text format     Abstract available


  101. XIN T, Chen M, Duan L, Xu Y, et al
    Interleukin-32: its role in asthma and potential as a therapeutic agent.
    Respir Res. 2018;19:124.
    PubMed     Text format     Abstract available


  102. ANZUETO AR, Kostikas K, Mezzi K, Shen S, et al
    Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.
    Respir Res. 2018;19:121.
    PubMed     Text format     Abstract available


  103. ESTIRADO C, Ceccato A, Guerrero M, Huerta A, et al
    Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.
    Respir Res. 2018;19:119.
    PubMed     Text format     Abstract available


  104. TOLEDO-PONS N, Noell G, Jahn A, Iglesias A, et al
    Bone marrow characterization in COPD: a multi-level network analysis.
    Respir Res. 2018;19:118.
    PubMed     Text format     Abstract available


  105. XU S, Vucic EA, Shaipanich T, Lam S, et al
    Decreased telomere length in the small airway epithelium suggests accelerated aging in the lungs of persons living with human immunodeficiency virus (HIV).
    Respir Res. 2018;19:117.
    PubMed     Text format     Abstract available


  106. MATUCCI A, Vultaggio A, Maggi E, Kasujee I, et al
    Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
    Respir Res. 2018;19:113.
    PubMed     Text format     Abstract available


  107. CARPAIJ OA, Muntinghe FOW, Wagenaar MB, Habing JW, et al
    Serum periostin does not reflect type 2-driven inflammation in COPD.
    Respir Res. 2018;19:112.
    PubMed     Text format     Abstract available


  108. VISHWESWARAIAH S, George L, Purushothaman N, Ganguly K, et al
    A candidate gene identification strategy utilizing mouse to human big-data mining: "3R-tenet" in COPD genetic research.
    Respir Res. 2018;19:92.
    PubMed     Text format     Abstract available


  109. KAHNERT K, Alter P, Welte T, Huber RM, et al
    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach.
    Respir Res. 2018;19:110.
    PubMed     Text format     Abstract available


  110. SUN J, Gu X, Wu N, Zhang P, et al
    Human antigen R enhances the epithelial-mesenchymal transition via regulation of ZEB-1 in the human airway epithelium.
    Respir Res. 2018;19:109.
    PubMed     Text format     Abstract available


  111. TWOREK D, Majewski S, Szewczyk K, Kiszalkiewicz J, et al
    The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
    Respir Res. 2018;19:108.
    PubMed     Text format     Abstract available


    May 2018
  112. JAAT FG, Hasan SF, Perry A, Cookson S, et al
    Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease.
    Respir Res. 2018;19:106.
    PubMed     Text format     Abstract available


  113. ALIAGAS E, Munoz-Esquerre M, Cuevas E, Careta O, et al
    Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.
    Respir Res. 2018;19:103.
    PubMed     Text format     Abstract available


  114. FISK M, Cheriyan J, Mohan D, McEniery CM, et al
    Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease.
    Respir Res. 2018;19:100.
    PubMed     Text format     Abstract available


  115. CLOOTS RHE, Poynter ME, Terwindt E, Lamers WH, et al
    Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma.
    Respir Res. 2018;19:98.
    PubMed     Text format     Abstract available


  116. GODTFREDSEN NS, Jorgensen DV, Marsaa K, Ulrik CS, et al
    Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
    Respir Res. 2018;19:97.
    PubMed     Text format     Abstract available


  117. BELVISI MG, Baker K, Malloy N, Raemdonck K, et al
    Modelling the asthma phenotype: impact of cigarette smoke exposure.
    Respir Res. 2018;19:89.
    PubMed     Text format     Abstract available


  118. GAO YH, Cui JJ, Wang LY, Yin KQ, et al
    Arterial stiffness in adults with steady-state bronchiectasis: association with clinical indices and disease severity.
    Respir Res. 2018;19:86.
    PubMed     Text format     Abstract available


  119. BULSEI J, Leroy S, Perotin JM, Mal H, et al
    Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).
    Respir Res. 2018;19:84.
    PubMed     Text format     Abstract available


  120. PERRY MM, Tildy B, Papi A, Casolari P, et al
    The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide.
    Respir Res. 2018;19:85.
    PubMed     Text format     Abstract available


    April 2018
  121. BLOECHLIGER M, Reinau D, Spoendlin J, Chang SC, et al
    Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.
    Respir Res. 2018;19:75.
    PubMed     Text format     Abstract available


  122. SCHWARZKOPF L, Witt S, Waelscher J, Polke M, et al
    Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis.
    Respir Res. 2018;19:73.
    PubMed     Text format     Abstract available


  123. BERG T, Hegelund-Myrback T, Ockinger J, Zhou XH, et al
    Expression of MATE1, P-gp, OCTN1 and OCTN2, in epithelial and immune cells in the lung of COPD and healthy individuals.
    Respir Res. 2018;19:68.
    PubMed     Text format     Abstract available


  124. LINDER R, Ronmark E, Pourazar J, Behndig AF, et al
    Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort.
    Respir Res. 2018;19:64.
    PubMed     Text format     Abstract available


  125. CHALMERS JD, Poole C, Webster S, Tebboth A, et al
    Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research
    Respir Res. 2018;19:63.
    PubMed     Text format     Abstract available


  126. DIAZ AA, Martinez CH, Harmouche R, Young TP, et al
    Pectoralis muscle area and mortality in smokers without airflow obstruction.
    Respir Res. 2018;19:62.
    PubMed     Text format     Abstract available


  127. OBEIDAT M, Zhou G, Li X, Hansel NN, et al
    The genetics of smoking in individuals with chronic obstructive pulmonary disease.
    Respir Res. 2018;19:59.
    PubMed     Text format     Abstract available


  128. GREULICH T, Hohlfeld JM, Neuser P, Lueer K, et al
    A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
    Respir Res. 2018;19:55.
    PubMed     Text format     Abstract available


    March 2018
  129. WANG J, Lv H, Luo Z, Mou S, et al
    Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
    Respir Res. 2018;19:47.
    PubMed     Text format     Abstract available


  130. VAN BUUL AR, Kasteleyn MJ, Chavannes NH, Taube C, et al
    Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms.
    Respir Res. 2018;19:49.
    PubMed     Text format     Abstract available


  131. SAKORNSAKOLPAT P, Morrow JD, Castaldi PJ, Hersh CP, et al
    Integrative genomics identifies new genes associated with severe COPD and emphysema.
    Respir Res. 2018;19:46.
    PubMed     Text format     Abstract available


  132. DE BROUWER B, Drent M, van den Ouweland JMW, Wijnen PA, et al
    Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis.
    Respir Res. 2018;19:45.
    PubMed     Text format     Abstract available


  133. PADILLA-GALO A, Olveira C, Fernandez de Rota-Garcia L, Marco-Galve I, et al
    Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.
    Respir Res. 2018;19:43.
    PubMed     Text format     Abstract available


  134. YANG M, Kohler M, Heyder T, Forsslund H, et al
    Proteomic profiling of lung immune cells reveals dysregulation of phagocytotic pathways in female-dominated molecular COPD phenotype.
    Respir Res. 2018;19:39.
    PubMed     Text format     Abstract available


  135. YANG M, Kohler M, Heyder T, Forsslund H, et al
    Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD.
    Respir Res. 2018;19:40.
    PubMed     Text format     Abstract available


  136. KERWIN EM, Spangenthal S, Kollar C, St Rose E, et al
    A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.
    Respir Res. 2018;19:38.
    PubMed     Text format     Abstract available


  137. PARK HY, Lee SY, Kang D, Cho J, et al
    Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
    Respir Res. 2018;19:36.
    PubMed     Text format     Abstract available


  138. CASTELLO LM, Bellan M
    Commenting on "Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from ACE 2 study" by Jacob A. Winther and colleagues.
    Respir Res. 2018;19:35.
    PubMed     Text format     Abstract available


    February 2018
  139. OSTRIDGE K, Williams NP, Kim V, Harden S, et al
    Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD.
    Respir Res. 2018;19:31.
    PubMed     Text format     Abstract available


  140. LEITAO FILHO FS, Ra SW, Mattman A, Schellenberg RS, et al
    Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.
    Respir Res. 2018;19:30.
    PubMed     Text format     Abstract available


  141. JOHNSON KM, Bryan S, Ghanbarian S, Sin DD, et al
    Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Respir Res. 2018;19:26.
    PubMed     Text format     Abstract available


    January 2018
  142. FAWZY A, Putcha N, Paulin LM, Aaron CP, et al
    Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.
    Respir Res. 2018;19:20.
    PubMed     Text format     Abstract available


  143. BREMNER PR, Birk R, Brealey N, Ismaila AS, et al
    Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
    Respir Res. 2018;19:19.
    PubMed     Text format     Abstract available


  144. MAHMUTOVIC PERSSON I, Menzel M, Ramu S, Cerps S, et al
    IL-1beta mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation.
    Respir Res. 2018;19:16.
    PubMed     Text format     Abstract available


  145. DI MARCO F, Sotgiu G, Santus P, O'Donnell DE, et al
    Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis.
    Respir Res. 2018;19:18.
    PubMed     Text format     Abstract available


  146. LARSSON K, Stallberg B, Lisspers K, Telg G, et al
    Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).
    Respir Res. 2018;19:12.
    PubMed     Text format     Abstract available


  147. OLLOQUEQUI J, Jaime S, Parra V, Cornejo-Cordova E, et al
    Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.
    Respir Res. 2018;19:13.
    PubMed     Text format     Abstract available


  148. MIRAVITLLES M, Roche N, Cardoso J, Halpin D, et al
    Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.
    Respir Res. 2018;19:11.
    PubMed     Text format     Abstract available


  149. USMANI OS, Lavorini F, Marshall J, Dunlop WCN, et al
    Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.
    Respir Res. 2018;19:10.
    PubMed     Text format     Abstract available


  150. MANORAK W, Idahosa C, Gupta K, Roy S, et al
    Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.
    Respir Res. 2018;19:1.
    PubMed     Text format     Abstract available


    December 2017
  151. BAO A, Yang H, Ji J, Chen Y, et al
    Involvements of p38 MAPK and oxidative stress in the ozone-induced enhancement of AHR and pulmonary inflammation in an allergic asthma model.
    Respir Res. 2017;18:216.
    PubMed     Text format     Abstract available


  152. GRAMEGNA A, Amati F, Terranova L, Sotgiu G, et al
    Neutrophil elastase in bronchiectasis.
    Respir Res. 2017;18:211.
    PubMed     Text format     Abstract available


  153. VARGAS A, Boivin R, Cano P, Murcia Y, et al
    Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Respir Res. 2017;18:207.
    PubMed     Text format     Abstract available


  154. KASTELEYN MJ, Bonten TN, de Mutsert R, Thijs W, et al
    Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study.
    Respir Res. 2017;18:205.
    PubMed     Text format     Abstract available


  155. WANG G, Zhang X, Zhang HP, Wang L, et al
    Corticosteroid plus beta2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.
    Respir Res. 2017;18:203.
    PubMed     Text format     Abstract available


    November 2017
  156. LO CY, Michaeloudes C, Bhavsar PK, Huang CD, et al
    Reduced suppressive effect of beta2-adrenoceptor agonist on fibrocyte function in severe asthma.
    Respir Res. 2017;18:194.
    PubMed     Text format     Abstract available


  157. ZHANG L, Zhang J, Gao P
    The potential of interleukin-37 as an effective therapeutic agent in asthma.
    Respir Res. 2017;18:192.
    PubMed     Text format     Abstract available


  158. DESCHILDRE A, Pichavant M, Engelmann I, Langlois C, et al
    Virus-triggered exacerbation in allergic asthmatic children: neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients.
    Respir Res. 2017;18:191.
    PubMed     Text format     Abstract available


  159. ROCHA NN, de Oliveira MV, Braga CL, Guimaraes G, et al
    Ghrelin therapy improves lung and cardiovascular function in experimental emphysema.
    Respir Res. 2017;18:185.
    PubMed     Text format     Abstract available


  160. PEREZ-DE-LLANO L, Cosio BG
    Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
    Respir Res. 2017;18:183.
    PubMed     Text format     Abstract available


    September 2017
  161. MENENDEZ R, Mendez R, Polverino E, Rosales-Mayor E, et al
    Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.
    Respir Res. 2017;18:176.
    PubMed     Text format     Abstract available


  162. TORAIH EA, Hussein MH, Al Ageeli E, Riad E, et al
    Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma.
    Respir Res. 2017;18:169.
    PubMed     Text format     Abstract available


    May 2017
  163. RAVI AK, Plumb J, Gaskell R, Mason S, et al
    COPD monocytes demonstrate impaired migratory ability.
    Respir Res. 2017;18:90.
    PubMed     Text format     Abstract available


  164. PUNEKAR YS, Sharma S, Pahwa A, Takyar J, et al
    Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis.
    Respir Res. 2017;18:86.
    PubMed     Text format     Abstract available


  165. KOLSUM U, Donaldson GC, Singh R, Barker BL, et al
    Blood and sputum eosinophils in COPD; relationship with bacterial load.
    Respir Res. 2017;18:88.
    PubMed     Text format     Abstract available


  166. DOMINGO E, Grignola JC, Aguilar R, Messeguer ML, et al
    Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.
    Respir Res. 2017;18:85.
    PubMed     Text format     Abstract available


  167. BODAS M, Vij N
    Augmenting autophagy for prognosis based intervention of COPD-pathophysiology.
    Respir Res. 2017;18:83.
    PubMed     Text format     Abstract available


  168. LAKHDAR R, Drost EM, MacNee W, Bastos R, et al
    2D-DIGE proteomic analysis of vastus lateralis from COPD patients with low and normal fat free mass index and healthy controls.
    Respir Res. 2017;18:81.
    PubMed     Text format     Abstract available


  169. MURRAY LA, Dunmore R, Camelo A, Da Silva CA, et al
    Acute cigarette smoke exposure activates apoptotic and inflammatory programs but a second stimulus is required to induce epithelial to mesenchymal transition in COPD epithelium.
    Respir Res. 2017;18:82.
    PubMed     Text format     Abstract available


  170. DUIVERMAN ML, Maagh P, Magnet FS, Schmoor C, et al
    Impact of High-Intensity-NIV on the heart in stable COPD: a randomised cross-over pilot study.
    Respir Res. 2017;18:76.
    PubMed     Text format     Abstract available


  171. WEIDNER J, Jarenback L, de Jong K, Vonk JM, et al
    Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
    Respir Res. 2017;18:77.
    PubMed     Text format     Abstract available


    April 2017
  172. OBEIDAT M, Nie Y, Chen V, Shannon CP, et al
    Network-based analysis reveals novel gene signatures in peripheral blood of patients with chronic obstructive pulmonary disease.
    Respir Res. 2017;18:72.
    PubMed     Text format     Abstract available


  173. MIRAVITLLES M, Ribera A
    Understanding the impact of symptoms on the burden of COPD.
    Respir Res. 2017;18:67.
    PubMed     Text format     Abstract available


  174. MATSUI H, Jo T, Fushimi K, Yasunaga H, et al
    Outcomes after early and delayed rehabilitation for exacerbation of chronic obstructive pulmonary disease: a nationwide retrospective cohort study in Japan.
    Respir Res. 2017;18:68.
    PubMed     Text format     Abstract available


  175. KHALAF RM, Lea SR, Metcalfe HJ, Singh D, et al
    Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi.
    Respir Res. 2017;18:61.
    PubMed     Text format     Abstract available


  176. KARL FM, Holle R, Bals R, Greulich T, et al
    Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
    Respir Res. 2017;18:60.
    PubMed     Text format     Abstract available


  177. CORDOBA-LANUS E, Cazorla-Rivero S, Espinoza-Jimenez A, de-Torres JP, et al
    Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.
    Respir Res. 2017;18:59.
    PubMed     Text format     Abstract available


    March 2017
  178. LEVAN TD, Smith LM, Heires AJ, Mikuls TR, et al
    Interaction of CD14 haplotypes and soluble CD14 on pulmonary function in agricultural workers.
    Respir Res. 2017;18:49.
    PubMed     Text format     Abstract available


  179. ROOS AB, Mori M, Gura HK, Lorentz A, et al
    Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF.
    Respir Res. 2017;18:48.
    PubMed     Text format     Abstract available


  180. NAMBA Y, Togo S, Tulafu M, Kadoya K, et al
    Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes.
    Respir Res. 2017;18:46.
    PubMed     Text format     Abstract available


    February 2017
  181. MARTINEZ CH, Freeman CM, Nelson JD, Murray S, et al
    GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
    Respir Res. 2017;18:42.
    PubMed     Text format     Abstract available


  182. BAZZAN E, Turato G, Tine M, Radu CM, et al
    Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity.
    Respir Res. 2017;18:40.
    PubMed     Text format     Abstract available


  183. WESTERIK JA, Metting EI, van Boven JF, Tiersma W, et al
    Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD.
    Respir Res. 2017;18:31.
    PubMed     Text format     Abstract available


    January 2017
  184. ZARCONE MC, van Schadewijk A, Duistermaat E, Hiemstra PS, et al
    Diesel exhaust alters the response of cultured primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD) to non-typeable Haemophilus influenzae.
    Respir Res. 2017;18:27.
    PubMed     Text format     Abstract available


  185. CAZZOLA M, Calzetta L, Facciolo F, Rogliani P, et al
    Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
    Respir Res. 2017;18:26.
    PubMed     Text format     Abstract available


  186. BLASI F, Canonica GW, Miravitlles M
    Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
    Respir Res. 2017;18:19.
    PubMed     Text format     Abstract available


  187. KAHNERT K, Lucke T, Biertz F, Lechner A, et al
    Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.
    Respir Res. 2017;18:14.
    PubMed     Text format     Abstract available


  188. SALOMON J, Stolz D, Domenighetti G, Frey JG, et al
    Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.
    Respir Res. 2017;18:13.
    PubMed     Text format     Abstract available


  189. TOPALOVIC M, Exadaktylos V, Troosters T, Celis G, et al
    Non-linear parameters of specific resistance loops to characterise obstructive airways diseases.
    Respir Res. 2017;18:9.
    PubMed     Text format     Abstract available


  190. REISNER C, Fabbri LM, Kerwin EM, Fogarty C, et al
    A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension Delivery Technology in patients with moderate-to-very severe chronic obstruct
    Respir Res. 2017;18:8.
    PubMed     Text format     Abstract available


  191. DANG X, Qu X, Wang W, Liao C, et al
    Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease.
    Respir Res. 2017;18:4.
    PubMed     Text format     Abstract available


  192. BATTAGLIA S, Scichilone N
    Eligibility of real-life patients with COPD for inclusion in RCTs: a commentary.
    Respir Res. 2017;18:5.
    PubMed     Text format     Abstract available


  193. SHUKLA SD, Mahmood MQ, Weston S, Latham R, et al
    The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL).
    Respir Res. 2017;18:6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: